Interestingly, in different studies individual LILRB1 antibodies differed in their activity to induce phagocytosis of tumor cells as single agent, which may be due to characteristics of target cells or of the antibody such as the isotype or the epitope specificity. The gene discussed is LILRB1; the disease is neoplasm.